Transferosomes as innovative drug delivery systems for enhanced antifungal therapy: A comprehensive review

Sakshi Chamel,Anamika Mishra,Azka Gull
DOI: https://doi.org/10.1016/j.jddst.2024.105545
IF: 5
2024-03-10
Journal of Drug Delivery Science and Technology
Abstract:A fungal infection or mycosis is a disease that can affect humans in various ways. These pathogens, being eukaryotic organisms, can invade their eukaryotic hosts, leading to superficial, sub-cutaneous, or systemic infections. Though most of the fungal infections are cutaneous, if the immune system is impaired, it can turn into systemic infection, having higher morbidity and mortality rates. Thus, antifungal drugs are necessary to treat these infections. Many conventional formulations are available against the fungi, but their uncontrolled use has proven the development of resistance to fungi. Antifungal moieties, mostly being lipophilic, are less absorbed through the oral route. Furthermore, their incorporation into nano delivery systems like liposomes and niosomes still struggle to cross the stratum corneum. Thus, using transferosomes can ease out the barrier-related problems to provide better penetration and permeation. Transferosomes are well-known vesicular carrier systems that can be a drug delivery system varying in drug ranges crossing the skin barriers. They gained popularity due to their ultra-deformable nature, which helps them to squeeze through the membrane and provide medication into the deeper tissues. Their small size, smaller PDI, better entrapment, sustained release, and safety make them a comfortable choice to deliver antifungal medications. This article explores their use on fungal infections and further provides better insight into their applicability, providing a better alternative to the conventional delivery systems available. Graphical abstract Download : Download high-res image (142KB) Download : Download full-size image
pharmacology & pharmacy
What problem does this paper attempt to address?